FDA Approves New Drug for Ulcerative Colitis FDA Approves New Drug for Ulcerative Colitis
Etrasimod is the second oral sphingosine-1-phosphate (S1P) receptor approved in the US for treating moderate to severe active ulcerative colitis in adults.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news
More News: Drugs & Pharmacology | Gastroenterology | Inflammatory Bowel Disease | Ulcerative Colitis